Candesartan in the Prevention of Relapsing Atrial Fibrillation
NCT00130975
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Atrial Fibrillation
Interventions
DRUG:
Candesartan
Sponsor
Asker & Baerum Hospital
Collaborators
[object Object]
[object Object]
[object Object]